Next round June 30th???

Anonymous

Guest
Anyone else hear the same thing? Don't think they will wait until end of year again. All the talk in Vegas about how we are where we want to be is garbage. More cuts but how will they do it this time?
 

<







Yep, be prepared, makes sense, cause most of the people cut that is about when the severance would have ended for them, they didn't want to do too many at once and take the big of loss, since Feb. 26th all the severance money hits!!! Be prepared and be looking!!
 












From the home office here. Oncology is next. Going down to 3 sales forces - Onc 1, 2, 3 portfolio selling and small PNET specialty force. Those getting within 5 years of retirement will get a buyout, others will be "displaced". Good luck everyone. June seems to look correct.
 




From the home office here. Oncology is next. Going down to 3 sales forces - Onc 1, 2, 3 portfolio selling and small PNET specialty force. Those getting within 5 years of retirement will get a buyout, others will be "displaced". Good luck everyone. June seems to look correct.

Thanks for the info. Any word on mass market?
 








what does novartis consider retirement age ? if your 55 with at least 10 years employment a buy out would be an interesting offer,especially if they paid you up to age 62 or something similar.
 








You have to have met the requirements I believe it was age plus years of service had to equal either 70 or 75 this was done two or three years ago. There is no pension program for you unless you met those requirements. Most of the tenured people who were let go fell into the grandfathered in category, that was part of Novartis's plan to reduce compensation. There is no fixed pension program just enhanced 401K
 
























I'm skeptical about this info, have 25 years with Novartis and have never seen them give an early buyout....other companies have, but not Novartis. It would be great if they did, I think many reps would take it as long as the medical credits came with the package...we shall see!
 




true, novartis has resisted the buyout, the only difference now is that there are fewer tenured reps so such an option may be more cost effective than previously.
Look, things are changing so fast that having high paid reps doesnt make sense. I dont care how tenured you are, the days of moving market share is not what it use to be. Relationships and creditability use to mean a lot but now access is limited and physicans have lost power to the insurance companies.
Replacing a tenured rep. with a newbie may not make that much difference to a territory yet it saves Novartis a ton of money in the long run ( grandfathered into pension plan etc).
 




true, novartis has resisted the buyout, the only difference now is that there are fewer tenured reps so such an option may be more cost effective than previously.
Look, things are changing so fast that having high paid reps doesnt make sense. I dont care how tenured you are, the days of moving market share is not what it use to be. Relationships and creditability use to mean a lot but now access is limited and physicans have lost power to the insurance companies.
Replacing a tenured rep. with a newbie may not make that much difference to a territory yet it saves Novartis a ton of money in the long run ( grandfathered into pension plan etc).

So true...thank you for the commentary Mr. Jimenez. Did you or Senior Leadership take cuts in bonus or salary? I think NOT. I bet your bonus is massive as you and the "upper-crust" continue to screw the employees as well as the stock holders. Congrats!
 




I know many reps in Oncology that are 50+ that would take a buyout as long as it was comparable to market conditions (IE 2-3 weeks of pay for every year of service in a lump sum, adding 5 years to pension/medical) this would be a win/win for everyone, and allow younger reps with less tenure to keep a position, allowing older reps nearing retirement to leave with a package. Lets hope that upper managment does the right thing!
 




Similar threads

Replies
39
Views
5K
Replies
11
Views
2K
Novartis
anonymous
Replies
7
Views
2K
Replies
28
Views
6K